SURGE Therapeutics

company

About

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$26M
Industries
Biotechnology
Number Of Employee
1 - 10
Operating Status
Active

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$26M
SURGE Therapeutics has raised a total of $26M in funding over 2 rounds. Their latest funding was raised on Oct 17, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 17, 2022 Series A $26M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
SURGE Therapeutics is funded by 1 investors. National Cancer Research Institute are the most recent investors.
Investor Name Lead Investor Funding Round
National Cancer Research Institute Series A